Shanda Interactive Entertainment Ltd. company information, Employees & Contact Information

NMPA Accepts sNDA for Frontline Toripalimab Plus Disitamab Vedotin in HER2+ Urothelial Carcinoma OncLive

FDA Accepts sNDA for Talazoparib/Enzalutamide in HRR-Mutant mCRPC CancerNetwork

Arcutis Submits sNDA for Roflumilast Cream 0.3% for Psoriasis in Children Aged 2-5 Years HCPLive

Arcutis Submits sNDA for Roflumilast Cream 0.3% to Treat Plaque Psoriasis in Patients as Young as 2 Dermatology Times

Rhythm Pharmaceuticals Announces FDA Acceptance of sNDA for Setmelanotide in Acquired Hypothalamic Obesity Yahoo Finance

BXCL501 for Agitation Associated With Bipolar Disorders or Schizophrenia: Positive Pre-sNDA Meeting With FDA Psychiatric Times

BioXcel Therapeutics Announces Positive FDA Pre-sNDA GlobeNewswire

FDA slaps CRL on Otsuka and Lundbeck’s Rexulti sNDA The Pharma Letter

scPharmaceuticals’ Furoscix sNDA gets FDA nod for CKD oedema Pharmaceutical Technology

FDA Accepts sNDA for Higher Dosing Regimen of Nusinersen for Spinal Muscular Atrophy NeurologyLive

First-Ever At-Home Agitation Drug: BioXcel's IGALMI Moves Closer to Outpatient Bipolar/Schizophrenia Use Stock Titan

FDA Accepts sNDA for Decitabine/Cedazuridine Combo in Newly Diagnosed AML CancerNetwork

FDA Removes Sparsentan (Filspari) Advisory Committee Meeting for FSGS sNDA HCPLive

FDA Accepts sNDA for Sotyktu in PsA Dermatology Times

sNDA for Sotyktu accepted for FDA review The Pharma Letter

Syndax Announces FDA Priority Review of sNDA for Revuforj® GlobeNewswire

FDA Receives sNDA for Relacorilant in Platinum-Resistant Ovarian Cancer CancerNetwork

FDA Accepts sNDA for Risperidone Extended-Release Injectable Suspension for Bipolar I Disorder HCPLive

FDA Accepts Finerenone sNDA for Heart Failure, Grants Priority Review HCPLive

APLS' Empaveli sNDA for 2 Rare Kidney Diseases Gets FDA Priority Tag Yahoo Finance

Travere Therapeutics Announces FDA Acceptance of sNDA for FILSPARI® (sparsentan) in FSGS Business Wire

FDA accepts sNDA for higher regimen nusinersen for spinal muscular atrophy Contemporary Pediatrics

FDA nod for scPharmaceuticals’ Furoscix sNDA The Pharma Letter

FDA APPROVES ACETADOTE® sNDA PR Newswire

China’s NMPA Accepts sNDA for Penpulimab Plus Anlotinib for Advanced HCC OncLive

Intra-Cellular Therapies Submits Supplemental New Drug GlobeNewswire

Landlord and tenant – Termination rights – SNDA Massachusetts Lawyers Weekly

Acalabrutinib/Venetoclax sNDA Under FDA Review for Previously Untreated CLL OncLive

China’s NMPA Accepts sNDA for Repotrectinib for NTRK+ Solid Tumors OncLive

sNDA Submitted to FDA for Venetoclax Plus Acalabrutinib in Untreated CLL CancerNetwork

Travere Therapeutics Submits sNDA for Sparsentan (Filspari) in FSGS HCPLive

Arcutis submits sNDA for roflumilast cream 0.3% for treatment of psoriasis in children 2-5 years Contemporary Pediatrics

FDA Accepts Sparsentan (Filspari) sNDA for Focal Segmental Glomerulosclerosis HCPLive

Alnylam Submits sNDA for Vutrisiran for Treatment of ATTR-CM HCPLive

FDA Accepts Pegcetacoplan (Empaveli) sNDA for C3G, IC-MPGN HCPLive

FDA Accepts sNDA for Community-acquired Pneumonia Drug respiratory-therapy.com

J&J Submits sNDA to FDA for Lumateperone (CAPLYTA) to Prevent Schizophrenia Relapse HCPLive

With sNDA, Travere Hopes to Expand Use of Sparsentan to FSGS Docwire News

Sonida Senior Living Inc (SNDA) Q2 2025 Earnings Call Highlights: Strong EBITDA Growth and ... Yahoo Finance

Arcutis Submits sNDA for Roflumilast Cream 0.05% to FDA for Patients Ages 2 to 5 with Atopic Dermatitis Dermatology Times

FDA Accepts Alnylam’s sNDA for Vutrisiran for ATTR-CM HCPLive

FDA accepts revised sNDA of IZERVAY for GA Eyes On Eyecare

FDA Extends Review of Obeticholic Acid (Ocaliva) sNDA for Primary Biliary Cholangitis HCPLive

We're Keeping An Eye On Sunda Energy's (LON:SNDA) Cash Burn Rate Yahoo Finance

FDA Accepts sNDA for Furosemide (Furoscix) in Chronic Kidney Disease HCPLive

FDA accepts sNDA for vibegron for OAB symptoms in pharmacologically treated BPH Urology Times

FDA accepts Taiho’s sNDA for Inqovi The Pharma Letter

FDA Accepts sNDA for Uzedy Extended-Release Injectable Suspension for Bipolar I Disorder Psychiatric Times

Xeris Announces Approval of Supplemental New Drug Application (sNDA) of Gvoke VialDx™ (glucagon) for Use as a Diagnostic Aid Yahoo Finance

Travere flops as FDA accepts Filspari sNDA but plans AdCom The Pharma Letter

FDA Accepts sNDA for Brexpiprazole for Adult Patients With PTSD Pharmacy Times

FDA Approves sNDA for Actinic Keratosis Drug Dosage Expansion Dermatology Times

BioXcel Therapeutics Aligns with FDA on sNDA for IGALMI Label Expansion to At-Home Use, Submission Planned for Q1 2026 Quiver Quantitative

Rapidly recovering and maintaining simultaneous partial nitrification, denitrification and anammox process through hydroxylamine addition to advance nitrogen removal from domestic sewage ScienceDirect.com

FDA Rejects sNDA of Tasimelteon for Treating Insomnia HCPLive

FDA Accepts Dermavant’s sNDA for Tapinarof Cream 1% for Adults and Children With AD Dermatology Times

FDA Accepts Agios' sNDA for Pyrukynd in Thalassemia Yahoo Finance

FDA Approves Wegovy's sNDA As Amended For Labeling With Minor Editorial Revisions TradingView

BioXcel Therapeutics receives FDA feedback ahead of planned pre-sNDA meeting Investing.com

sNDA Submitted: Spravato as Monotherapy for Treatment-Resistant Depression Psychiatric Times

AbbVie submits sNDA for functional constipation treatment in pediatric patients Healio

Otsuka and Lundbeck Announce FDA Acceptance of sNDA Filing for Brexpiprazole in Combination With Sertraline for the Treatment of Adults With Post-Traumatic Stress Disorder (PTSD) Business Wire

FDA Approves sNDA for Rexulti for Adolescents With Schizophrenia Pharmacy Times

Sunda Energy (AIM: SNDA) Targets H1 2026 for Chuditch Well Drilling Share Talk

FDA Grants Priority Review for Vascepa sNDA Diagnostic and Interventional Cardiology

Fourth-Annual SNDA Impressions Day a Great Success Boston University